Oslo, 16 October 2025
Reference is made to the announcement by Observe Medical ASA (the "Company" or
"Observe Medical", OSE ticker "OBSVR") on 10 October 2025 regarding the
extraordinary general meeting's resolution to increase the share capital of the
Company by the issuance of 20,000,000 new shares to Songa Capital AS and four
affiliated companies in connection with a private placement, at a subscription
price of NOK 0.50 per share (the "Private Placement").
The share capital increase pertaining to the Private Placement has today been
registered with the Norwegian Register of Business Enterprises (Nw.
Foretaksregisteret). The Company's registered share capital is NOK 47,102,333.04
divided into 112,148,412 shares, each with a nominal value of NOK 0.42.
The new shares will be issued in the Norwegian Central Securities Depository (ES
-OSL) on the listed ISIN NO NO0013457952 and are expected to be delivered to the
respective subscribers' ES-OSL accounts on 17 October 2025.
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical:
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialisation of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.